ADRA1D Antikörper (AA 286-335)

Produktnummer ABIN6746725

Produktdetails anti-ADRA1D Antikörper

Target: ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))

Bindungsspezifität: AA 286-335

Reaktivität: Human, Ratte, Maus, Pferd, Hund, Affe, Schwein, Kaninchen, Rind (Kuh), Meerschweinchen, Fledermaus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ADRA1D Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: Human ADRA1D

Homologie: Percent identity by BLAST analysis: Human, Dog, Bovine, Rabbit, Pig, Guinea pig (100%) Sheep (92%) Mouse, Rat (85%).

Aufreinigung: Immunoaffinity purified

Immunogen: Synthetic peptide located between aa286-335 of human ADRA1D (P25100, NP_000669). Percent identity by BLAST analysis: Human, Gorilla, Monkey, Galago, Marmoset, Dog, Bovine, Bat, Rabbit, Horse, Pig, Guinea pig (100%), Sheep (92%), Mouse, Rat (85%).

Type of Immunogen: Synthetic peptide

Anwendungsinformationen

Applikationshinweise: Approved: WB (0.2 - 1 μg/mL)

Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Distilled water

Konzentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Handhabung: Avoid repeat freeze-thaw cycles.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Referenzen für anti-ADRA1D Antikörper (ABIN6746725)

Mirski, Gerlach, Cole: "Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II." in: Experimental cell research, Vol. 251, Issue 2, pp. 329-39, (1999) (PubMed).

Brown, Holden, Rahn, Perkins: "Immunohistochemical staining for DNA topoisomerase IIa in Hodgkin's disease." in: American journal of clinical pathology, Vol. 109, Issue 1, pp. 39-44, (1998) (PubMed).

Herzog, Holmes, Tuschong, Ganapathi, Zwelling: "Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha." in: Cancer research, Vol. 58, Issue 23, pp. 5298-300, (1998) (PubMed).

Details zu ADRA1D

Target: ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))

Andere Bezeichnung: ADRA1D (ADRA1D Produkte)

Synonyme: Adra-1 antikoerper, Adra1 antikoerper, Adra1a antikoerper, Gpcr8 antikoerper, Spr8 antikoerper, [a]1d antikoerper, alpha1D-AR antikoerper, Adrd1 antikoerper, ADRA1 antikoerper, ADRA1A antikoerper, ADRA1R antikoerper, ALPHA1 antikoerper, DAR antikoerper, dJ779E11.2 antikoerper, adrenergic receptor, alpha 1d antikoerper, adrenoceptor alpha 1D antikoerper, Adra1d antikoerper, ADRA1D antikoerper

Hintergrund: Name/Gene ID: ADRA1D
Subfamily: Adrenergic
Family: GPCR

Synonyms: ADRA1D, Alpha 1d, Alpha-1D adrenergic receptor, ADRA1R, Alpha-1D adrenoceptor, Alpha-1D adrenoreceptor, ALPHA1, Alpha-1D-adrenergic receptor, Alpha-adrenergic receptor 1a, Alpha1delta-AR, DAR, ADRA1, Adrenoceptor alpha 1D, Alpha-1A adrenergic receptor, DJ779E11.2

Gen-ID: 146

NCBI Accession: NP_000669

UniProt: P25100